Insider trades appear within seconds, the rest within the hour.

Get alerts

← Feed

COAGNasdaq

Hemab Therapeutics Holdings, Inc.

Alert me on COAG
4
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

Six months

After each filing

22
Jun 18 Buy RA CAPITAL MANAGEMENT, L.P. Insider
1 week
+10.7%S&P −2.4%
1 month
+65.1%S&P +0.2%
3 months
+40.9%S&P +2.3%
6 months
Result in27 trading days
Jun 18 Buy RA Capital Healthcare Fund LP Insider
1 week
+10.7%S&P −2.4%
1 month
+65.1%S&P +0.2%
3 months
+40.9%S&P +2.3%
6 months
Result in27 trading days
Jun 18 Buy Kolchinsky Peter Insider
1 week
+10.7%S&P −2.4%
1 month
+65.1%S&P +0.2%
3 months
+40.9%S&P +2.3%
6 months
Result in27 trading days
Jun 18 Buy Shah Rajeev M. Insider
1 week
+10.7%S&P −2.4%
1 month
+65.1%S&P +0.2%
3 months
+40.9%S&P +2.3%
6 months
Result in27 trading days
May 22 Buy RA CAPITAL MANAGEMENT, L.P. Insider
1 week
+4.8%S&P +1.7%
1 month
+11.1%S&P −1.4%
3 months
+80.3%S&P +2.7%
6 months
Result in9 trading days
Show all 22
May 22 Buy RA Capital Healthcare Fund LP Insider
1 week
+4.8%S&P +1.7%
1 month
+11.1%S&P −1.4%
3 months
+80.3%S&P +2.7%
6 months
Result in9 trading days
May 22 Buy Kolchinsky Peter Insider
1 week
+4.8%S&P +1.7%
1 month
+11.1%S&P −1.4%
3 months
+80.3%S&P +2.7%
6 months
Result in9 trading days
May 22 Buy Shah Rajeev M. Insider
1 week
+4.8%S&P +1.7%
1 month
+11.1%S&P −1.4%
3 months
+80.3%S&P +2.7%
6 months
Result in9 trading days
May 15 Buy RA CAPITAL MANAGEMENT, L.P. Insider
1 week
−7.8%S&P +0.9%
1 month
−9.1%S&P +1.5%
3 months
+90.9%S&P +4.8%
6 months
Result in4 trading days
May 15 Buy RA Capital Healthcare Fund LP Insider
1 week
−7.8%S&P +0.9%
1 month
−9.1%S&P +1.5%
3 months
+90.9%S&P +4.8%
6 months
Result in4 trading days
May 15 Buy Kolchinsky Peter Insider
1 week
−7.8%S&P +0.9%
1 month
−9.1%S&P +1.5%
3 months
+90.9%S&P +4.8%
6 months
Result in4 trading days
May 15 Buy Shah Rajeev M. Insider
1 week
−7.8%S&P +0.9%
1 month
−9.1%S&P +1.5%
3 months
+90.9%S&P +4.8%
6 months
Result in4 trading days
May 12 Buy RA CAPITAL MANAGEMENT, L.P. Insider
1 week
−1.8%S&P −0.6%
1 month
+4.0%S&P −0.1%
3 months
+106.5%S&P +4.9%
6 months
Result in1 trading day
May 12 Buy RA Capital Healthcare Fund LP Insider
1 week
−1.8%S&P −0.6%
1 month
+4.0%S&P −0.1%
3 months
+106.5%S&P +4.9%
6 months
Result in1 trading day
May 12 Buy Kolchinsky Peter Insider
1 week
−1.8%S&P −0.6%
1 month
+4.0%S&P −0.1%
3 months
+106.5%S&P +4.9%
6 months
Result in1 trading day
May 12 Buy Shah Rajeev M. Insider
1 week
−1.8%S&P −0.6%
1 month
+4.0%S&P −0.1%
3 months
+106.5%S&P +4.9%
6 months
Result in1 trading day
May 7 Buy RA CAPITAL MANAGEMENT, L.P. Insider
1 week
+10.2%S&P +2.3%
1 month
−0.7%S&P +1.0%
3 months
+92.9%S&P +6.0%
6 months
+77.0%S&P +0.7%
May 7 Buy RA Capital Healthcare Fund LP Insider
1 week
+10.2%S&P +2.3%
1 month
−0.7%S&P +1.0%
3 months
+92.9%S&P +6.0%
6 months
+77.0%S&P +0.7%
May 7 Buy RA Capital Nexus Fund II, L.P. Insider
1 week
+10.2%S&P +2.3%
1 month
−0.7%S&P +1.0%
3 months
+92.9%S&P +6.0%
6 months
+77.0%S&P +0.7%
May 7 Buy RA Capital Nexus Fund IV, L.P. Insider
1 week
+10.2%S&P +2.3%
1 month
−0.7%S&P +1.0%
3 months
+92.9%S&P +6.0%
6 months
+77.0%S&P +0.7%
May 7 Buy Kolchinsky Peter Insider
1 week
+10.2%S&P +2.3%
1 month
−0.7%S&P +1.0%
3 months
+92.9%S&P +6.0%
6 months
+77.0%S&P +0.7%
May 7 Buy Shah Rajeev M. Insider
1 week
+10.2%S&P +2.3%
1 month
−0.7%S&P +1.0%
3 months
+92.9%S&P +6.0%
6 months
+77.0%S&P +0.7%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for COAG

20 held · newest 520 held · newest 2
Loading the filings.
See all 20 filings for COAG

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
No lobbying reports on file.